RxDoctor Payments Data

Ashlyn Buttermore

Physician Assistant · Fort Wayne, INNPI 1871260125

Payments from drug & device makers

$1,778in general payments, 2019–2025

Across 104 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$533
  • AbbVie$229
  • Endo Pharmaceuticals Inc.$218
  • Johnson & Johnson$192
  • Teleflex LLC$125
  • Convatec Inc.$92
  • plus $389 from 12 others

What the payments were for

  • Food & beverage$1,778100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,778 in reported general payments places this provider in the 80th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana

Medicare billing

Part B allowed, 2024
$23,973
Medicare patients
213
Services billed
362

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron115$78,487
MyrbetriqMirabegron89$67,528
Tamsulosin Hcl290$3,210
Potassium Citrate ErPotassium Citrate42$2,180
Trospium Chloride14$1,458
Testosterone12$1,405
Tolterodine Tartrate15$758
Finasteride56$661
Cephalexin104$627
Alfuzosin Hcl ErAlfuzosin Hcl27$576
Solifenacin Succinate31$465
Testosterone Cypionate14$308
Dutasteride12$292
Oxybutynin Chloride ErOxybutynin Chloride21$220
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst17$192

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$533$78,487115 claims
Astellas Pharma US IncMyrbetriq$21$67,52889 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Fort Wayne

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →